Farmaseuttisen kemian laitos
Department of Pharmaceutical Chemistry

Julkaisut 2004
Publications 2004

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Callaway JC. Hemp seed production in Finland.
2 Callaway JC. Hempseed as a nutritional resource: An overview.
3 de Graaf M et al. A methylester of the glucuronide prodrug DOX-GA3 for improvement of tumor-selective chemotherapy.
4 Forsberg MM et al. Lack of increased oxidative stress in catechol-O-methyltransferase (COMT)-deficient mice.
5 Hanisch U-K et al. The microglia-activating potential of thrombin.
6 Holappa J et al. Synthesis and characterization of chitosan N-betainates having various degrees of substitution.
7 Holappa J et al. Synthesis and characterization of chitosan N-betainates with various degrees of substitution.
8 Honkakoski P et al. Effects of triaryl phosphates on mouse and human nuclear receptors.
9 Jarho EM et al. A cyclopent-2-enecarbonyl group mimics proline at the P2 position of prolyl oligopeptidase inhibitors.
10 Jarho P et al., keksijä. Uudet luonnon syklodekstriinin kompleksit.
11 Kanninen K et al. Glycosylation changes in Alzheimer's disease as revealed by a proteomic approach.
12 Kinnarinen T et al. Cyclodextrins in pulmonary drug delivery: in vitro toxicity of cyclodextrins in calu-3 cells.
13 Koistinen R et al. Kasvun vuosikymmen. Kuopion yliopiston farmaseuttinen tiedekunta 30 vuotta.
14 Kärkkäinen M et al. Partial amino acid sequence of a cellullase-like component with IgE-binding properties from stachybotrys chartarum.
15 Laine K. Intraocular Pressure Lowering Activities of Endogenous Cannabinoids, and Their Uptake and Enzyme Hydrolysis Inhibitors in Normotensive Rabbits.
16 Laine K. Elimistön kannabinoidijärjestelmään vaikuttavat yhdisteet alentavat kaniinien silmänpainetta.
17 Mannila A, Savolainen J. Veri-aivoeste - este tehokkaan lääkeaineen ja tehokkaan lääkehoidon välissä.
18 Mannila J et al. Determination of delta9 -tetrahydrocannabinol from rabbit plasma by gas chromatography-mass spectrometry using two ionization techniques.
19 Mauriala T et al. HPLC electrospray mass spectrometric characterization of trimeric building blocks for oligonucleotide synthesis.
20 Mauriala T et al. Determination of long-chain fatty acid acyl-coenzyme A compounds using liquid chromatography-electrospray ionization tandem mass spectrometry.
21 Mäntylä A. Synthesis and In Vitro Evaluation of Novel Buparvaquone Prodrugs for the Treatment of Leishmaniasis.
22 Mäntylä A et al. Synthesis, in vitro evaluation, and antileishmanial activity of water-soluble prodrugs of buparvaquone.
23 Mäntylä A et al. Synthesis and antileishmanial activity of novel buparvaquone oxime derivatives.
24 Näsi E, Rautio J. Lääkeaineiden ihonläpäisevyyttä parantavat menetelmät.
25 Paananen H et al. Evaluation of exposure to man-made vitreous fibers by nasal lavage.
26 Palmgrén J et al. Characterization of Caco-2 cell monolayer drug transport properties by cassette dosing using UV/fluorescence HPLC.
27 Parkkari T et al. Synthesis and CB1 receptor activities of novel arachidonyl alcohol derivatives.
28 Puleo A et al. Chemical and enzymatic stability evaluation of lipoamino acid esters of idebenone.
29 Rautio J, Chikhale PJ. Drug delivery systems for brain tumor therapy.
30 Saarelainen S et al. Assessment of recombinant dog allergens Can f 1 and Can f 2 for the diagnosis of dog allergy.
31 Saario SM et al. Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes .
32 Salo OMH et al. Development of a 3D model for the human cannabinoid CB1 receptor.
33 Savinainen JR, Laitinen JT. Detection of cannabinoid CB1, adenosine A1, muscarinic acetylcholine, and GABAB receptor-dependent G protein activity in transducin-deactivated membranes and autoradiography sections of rat retina.
34 Tennilä T et al. Selective circular oligonucleotide probes improve detection of point mutations in DNA.
35 Tervo AJ et al. An in silico approach to discovering novel inhibitors of human sirtuin type 2.
36 Tervo AJ et al. Comparing the quality and predictiveness between 3D QSAR models obtained from manual and automated alignment.
37 Tuovinen L et al. Drug release from starch-acetate microparticles and films with and without incorporated alfa-amylase.
38 Tuovinen L et al. Starch acetate microparticles for drug delivery into retinal pigment epithelium - in vitro study.
39 Venäläinen JI et al. Slow-binding inhibitors of prolyl oligopeptidase with different functional groups at the P1 site.
40 Wallén E. Uusien prolyylioligopeptidaasi-estäjien suunnittelu ja synteesi.
41 Windshügel B et al. Molecular dynamics simulations of the human CAR ligand-binding domain: deciphering the molecular basis for constitutive activity.

Farmaseuttisen kemian laitos Department of Pharmaceutical Chemistry
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008